4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000179
Chairperson & CEO sold 7,777 shares at an average $599.64 ($4,663,396)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
25 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-04 | Sale : show line 2 in the form 10b5-1 | −39 | $580.70 | $22,647 | 333,904 | I |
| 2026-11-04 | Sale : show line 3 in the form 10b5-1 | −133 | $582.18 | $77,429 | 333,771 | I |
| 2026-11-04 | Sale : show line 4 in the form 10b5-1 | −188 | $583.18 | $109,639 | 333,583 | I |
| 2026-11-04 | Sale : show line 5 in the form 10b5-1 | −80 | $584.14 | $46,731 | 333,503 | I |
| 2026-11-04 | Sale : show line 6 in the form 10b5-1 | −280 | $585.60 | $163,969 | 333,223 | I |
| 2026-11-04 | Sale : show line 7 in the form 10b5-1 | −280 | $586.92 | $164,337 | 332,943 | I |
| 2026-11-04 | Sale : show line 8 in the form 10b5-1 | −400 | $588.21 | $235,284 | 332,543 | I |
| Open-market sales · 7,777 sh · avg $599.64 · $4,663,396 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-04 | Exercise or conversion : show line 26 in the form 10b5-1 Stock Option | −9,500 | 90,910 | I |
Loading xslF345X06/primarydocument.xml…